← Back to Search

Virtual Reality Therapy for Chemotherapy Discomfort

N/A
Waitlist Available
Led By Cody Stansel, MSN
Research Sponsored by Cody Stansel
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Not currently experiencing any contagious conditions, infections, or diseases (particularly of the eyes, skin, or scalp)
No previous history of seizures, losses of awareness, or other symptoms linked to an epileptic condition
Timeline
Screening 3 weeks
Treatment Varies
Follow Up approximately 12 months
Awards & highlights

Study Summary

This trial will test whether virtual reality can help distract patients from the discomfort of chemotherapy and improve their experience.

Who is the study for?
This trial is for English-speaking adults over 18 with cancer, who are getting chemotherapy but don't have devices like pacemakers, aren't prone to motion sickness or seizures, and aren't taking certain heart medications. They shouldn't be contagious or have eye, skin, scalp infections.Check my eligibility
What is being tested?
The study tests if virtual reality can help distract patients from pain and stress during chemo sessions in the infusion clinic. It includes wearing VR gear while undergoing treatment and monitoring heart rate changes and any signs of cyber sickness.See study design
What are the potential side effects?
While not drug-related, side effects may include discomfort from wearing VR equipment or feelings of nausea due to motion sensitivity (cyber sickness), especially for those who might be sensitive to immersive environments.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I do not have any contagious illnesses right now.
Select...
I have never had seizures or unexplained losses of awareness.
Select...
I am not currently undergoing treatment with radioactive drugs.
Select...
I am not on medication for irregular heartbeats.
Select...
I am 18 years old or older.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~approximately 12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and approximately 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Measure the affect of Virtual Reality Therapy on improving pain
Measure the affect of Virtual Reality Therapy on improving stress
Positive or negative effect of Virtual Reality therapy on improving the experience of participants receiving chemotherapy
Secondary outcome measures
Rate of cyber sickness (Virtual Reality Therapy Arm Only)

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Virtual Reality TherapyExperimental Treatment4 Interventions
Participants will watch videos for 11 minutes that will allow them to view nature, dinosaurs, animals, and human interactions in three dimension.
Group II: Control GroupActive Control2 Interventions
This group will not watch videos, but will continue with their normal routine as if nothing has changed.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Questionnaires
2013
Completed Phase 2
~3330

Find a Location

Who is running the clinical trial?

Cody StanselLead Sponsor
Cody Stansel, MSNPrincipal InvestigatorVanderbilt-Ingram Cancer Center

Media Library

Virtual reality therapy Clinical Trial Eligibility Overview. Trial Name: NCT05135260 — N/A
Cancer Research Study Groups: Control Group, Virtual Reality Therapy
Cancer Clinical Trial 2023: Virtual reality therapy Highlights & Side Effects. Trial Name: NCT05135260 — N/A
Virtual reality therapy 2023 Treatment Timeline for Medical Study. Trial Name: NCT05135260 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many participants are being included in the scope of this clinical research?

"Affirmative. Clinicaltrials.gov confirms that this clinical trial, initially posted on November 1st 2021, is presently seeking out patients to enrol in the study. The research requires 100 participants from a single medical centre."

Answered by AI
~29 spots leftby Apr 2025